Anna Drabkin

Title: Anna Drabkin: Innovator in Pharmaceutical Microparticles

Introduction

Anna Drabkin is a notable inventor based in Tzur Hadassah, Israel. She has made significant contributions to the field of pharmaceuticals, particularly in the development of drug delivery systems. With a focus on innovative microparticle technology, her work has the potential to enhance the efficacy of various medications.

Latest Patents

Anna Drabkin holds 2 patents that showcase her expertise in pharmaceutical formulations. Her latest patents include "Risperidone microparticles formed by sublimation," which provides microparticles of active pharmaceutical ingredients, drug delivery vehicles comprising the same, and methods for making them. Another significant patent is "Drug microparticles, processes of preparing them and a drug delivery vehicle comprising them," which details the preparation of microparticles by removing a sublimable carrier from a solid solution of active pharmaceutical ingredients.

Career Highlights

Drabkin is associated with Teva Pharmaceutical Industries Limited, a leading global pharmaceutical company. Her work at Teva emphasizes her commitment to advancing drug delivery technologies and improving patient outcomes through innovative solutions.

Collaborations

Throughout her career, Anna has collaborated with esteemed colleagues such as E Itzhak Lerner and Vered Rosenberger. These partnerships have contributed to her success and the advancement of her research in the pharmaceutical field.

Conclusion

Anna Drabkin is a pioneering inventor whose work in pharmaceutical microparticles is making a significant impact in drug delivery systems. Her innovative patents and collaborations highlight her dedication to improving healthcare through science and technology.